Monthly Archives: March 2023
Nausea, Vomiting, and Abdominal Distention after Atrial Fibrillation Therapy
Refining classification of cholangiocarcinoma subtypes via proteogenomic integration reveals new therapeutic prospects
Intrahepatic cholangiocarcinomas (iCCs) are characterized by their rarity, difficult diagnosis, and overall poor prognosis. The iCC molecular classification for developing precision medicine strategies was investigated. Continue reading
In Memorium: William Y Chey, MD, DSc, AGAF, FACG
Host sorbitol and bacterial sorbitol utilization promote C. difficile infection in inflammatory bowel disease
Inflammatory bowel disease (IBD) is a widespread gastrointestinal inflammatory disorder with globally increasing incidence. Clostridioides difficile infection (CDI) often occurs in patients with intestinal dysbiosis, such as after antibiotic therapy. I… Continue reading
Abdominal Pain—An Ambiguous Pancreatic Cyst
Disease etiology and outcomes after atezolizumab plus bevacizumab in hepatocellular carcinoma: Post-hoc analysis of IMbrave150
Colorectal Neoplasia 10 Years or More Following Negative Colonoscopy: Time to Extend Recommended Surveillance Intervals?
Factor analysis of the Rome IV criteria for major disorders of gut-brain interaction (DGBI) globally and across geographical, sex and age groups
The Rome criteria are widely accepted for diagnosing disorders of gut-brain interaction (DGBI), but their global applicability has been debated. This study aimed to evaluate the validity of the Rome IV criteria by factor analysis globally, across geogr… Continue reading